Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhaled budesonide/formoterol combination.

J K McGavin1, K L Goa, B Jarvis

  • 1Adis International Limited, Mairangi Bay, Auckland, New Zealand. demail@adis.co.nz

Drugs
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Velnacrine in Alzheimer's Disease : An Initial Appraisal of its Clinical Potential.

CNS drugs·2016
Same author

Reconsideration of the derivation of Most Probable Numbers, their standard deviations, confidence bounds and rarity values.

Journal of applied microbiology·2015
Same author

Application of Illumina next-generation sequencing to characterize the bacterial community of the Upper Mississippi River.

Journal of applied microbiology·2013
Same author

Stachybotrys: An unusual mold associated with water-damaged buildings.

Mycotoxin research·2013
Same author

Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

CNS drugs·2013
Same author

Reconsideration of the derivation of Most Probable Numbers, their standard deviations, confidence bounds and rarity values.

Journal of applied microbiology·2010

Combining budesonide and formoterol improves lung function and reduces asthma exacerbations in adults and children. This combination therapy shows no adverse drug interactions and is well-tolerated, with common side effects including respiratory infections.

Area of Science:

  • Pulmonology
  • Pharmacology

Background:

  • Asthma management often involves inhaled corticosteroids (ICS) and long-acting beta2-agonists (LABA).
  • Budesonide (ICS) and formoterol (LABA) are commonly prescribed for asthma.
  • The efficacy and safety of combining budesonide and formoterol require ongoing evaluation.

Purpose of the Study:

  • To assess the effectiveness of combining budesonide and formoterol in improving lung function and reducing asthma exacerbations.
  • To evaluate the safety and tolerability of concurrent budesonide/formoterol therapy.

Main Methods:

  • Review of current evidence on budesonide/formoterol combination therapy.
  • Analysis of clinical trial data regarding lung function parameters (Peak Expiratory Flow, FEV1) and symptom control.
  • Assessment of pharmacokinetic, pharmacodynamic, and adverse effect profiles.

Related Experiment Videos

Main Results:

  • Combination therapy significantly improves lung function (morning/evening PEFR, FEV1) in adults and children with persistent asthma.
  • Budesonide/formoterol effectively reduces asthma symptom severity and exacerbation incidence.
  • No significant adverse interactions affecting drug profiles or safety were observed.

Conclusions:

  • Combined budesonide/formoterol is an effective and safe treatment option for persistent asthma across age groups.
  • The combination enhances lung function and symptom control without compromising safety.
  • This therapeutic approach offers a valuable strategy for managing asthma effectively.